They react to everything, their symptoms span every organ system, and nothing holds. MCAS is not a mystery - it's a pattern. This lecture teaches you to recognize it, diagnose it, and systematically treat it.
Get Instant Access - $349
Up to 17% of the first-world population is estimated to have MCAS. It presents differently in every patient - skin, gut, brain, cardiovascular, neurological - which is exactly why it gets missed for years.
Mast cell activation inflames the entire system. Without controlling it first, every other therapy destabilizes the patient. This lecture teaches you exactly where MCAS sits in the treatment hierarchy - and what to address before and after it.
The Hoffman Centre is known globally as one of the top MCAS clinics in the world. Dr. Hoffman co-authored the Consensus 2 diagnostic criteria with Dr. Lawrence Afrin. This is that clinical knowledge, structured and transferred.
From the biology of mast cells to real prescription examples from Dr. Hoffman's own practice, this lecture covers the full diagnostic and treatment picture - including the POTS connection that most practitioners overlook.
What mast cells actually do, why they become dysregulated, and why MCAS is the ultimate expression of a "stuck" Cell Danger Response in a toxic modern world. Covers the history of the diagnosis from 1869 to Consensus 2.
A complete organ-by-organ breakdown of MCAS symptoms across skin, GI, cardiovascular, neurological, psychiatric, musculoskeletal, hormonal, and coagulation systems - so you finally know what you're looking for in your most complex patients.
The updated diagnostic framework Dr. Hoffman co-authored, including lab markers, the role of tryptase, histamine, and mediator testing, differential diagnosis (systemic mastocytosis, carcinoid, pheochromocytoma), and how to avoid misdiagnosis.
The full treatment stack: Paleo-Autoimmune Low-Histamine dietary protocols, Dr. Hoffman's A, B, and C-team supplements (DAO enzymes, quercetin, PEA, NeuroProtek, Nigella sativa, and more), MCAS-safe probiotics, and compounded pharmaceutical options with real dosing examples.
Why POTS and MCAS almost always co-present, how autonomic dysfunction connects to mold, Lyme, and trauma, and how to support fluid balance, vagal tone, and adrenal function so your MCAS treatment can actually hold.
Tilt table testing, active stand test, poor man's TTT, and the diagnostic criteria that distinguishes POTS from other forms of dysautonomia. Includes the subtypes (hyperadrenergic, neuropathic, hypovolemic) and how each shapes treatment.
Salt loading, fluid strategies, compression, exercise rehabilitation (the CHOP protocol), beta blockers, fludrocortisone, midodrine, and the interventions Dr. Hoffman has found most effective across 30 years of complex dysautonomia cases.
The framework that explains why so many complex patients have MCAS, POTS, and hypermobility (EDS) together, and how understanding this constellation changes the way you approach the whole case - not just the MCAS.
Dr. Hoffman did not stumble into MCAS; he helped define it within the context of treating chronic complex illness and the Cell Danger Response.
Dr. Hoffman starts noticing more and more multi-system, multi-symptom patients whose diagnoses struggle to fit under any previously understood disease process. Something else is happening.
Invited to the inaugural MCAS conference at Common Weal, San Francisco, alongside Dr. Mark Renneker and Dr. Larry Afrin. Dr. Andy Maxwell presents the concept of the triad and pentad for the first time. A new clinical framework is born.
Through dialogue with colleagues, Mast Cell Activation becomes the explanation for what Dr. Hoffman has been seeing for years. The Hoffman Centre begins developing its MCAS treatment approach in earnest.
Dr. Hoffman joins Dr. Lawrence Afrin and a core international group of physicians to co-author Consensus 2 - a new global diagnostic proposal for MCAS that is still used by leading practitioners worldwide.
Dr. Hoffman connects the dots between MCAS, POTS, the Cell Danger Response, and the Health Cycle Principles - establishing a sequenced treatment approach. The Hoffman Centre becomes known as one of the top MCAS clinics in the world, drawing patients from across the globe to Calgary.
We'd read Naviaux's work and understood CDR to some level, but we didn't know what to do about it. After this lecture, we all have a clear plan: what to address first, and what to absolutely leave out. We are grateful you are sharing this wisdom.
This isn't another algorithm or protocol - it's a reorientation to what medicine actually is. It reconnects you with the art, intuition, and consciousness behind clinical practice. If you're tired of chasing data and ready to actually see patients, do it.
Traditional medicine, the way that we learned it in medical school, is incomplete. Understanding what I have learned now, I find it criminal that what Dr. Hoffman does isn't used in standard clinical medicine.
I co-authored the global Consensus 2 diagnostic criteria for MCAS. My clinic has treated patients who flew in from six continents to be seen.
Over 30 years of treating the most complex cases in integrative medicine, MCAS became the condition I kept coming back to - because it's at the centre of almost every case that doesn't resolve. I built a sequenced approach to treating it, refined it across thousands of patients, and now I'm teaching it. Not as a protocol. As a way of understanding.
Get Instant AccessThis lecture is for anyone who wants to understand MCAS at the level Dr. Hoffman teaches it - from biology to bedside.
30 years of MCAS clinical experience, 128 slides, 8 core topics. One lecture that changes how you see your most reactive patients.
The complete MCAS and POTS lecture from Dr. Bruce Hoffman - one of the world's leading MCAS clinicians and co-author of Consensus 2.
Common questions about the MCAS lecture